Speaking to reporters at the drug launch, Vikrant Shrotriya, MD, Novo Nordisk India, said that bringing the therapy under this price bracket was a "tough decision," and the brands current pricing is virtually in line with that of insulins
N Engl J Med 2015;373:11-22.ArticlePubMed 21
I was pretty desperate to get it at that point, she told us, especially because I was seeing so many other peoples results and got major FOMO. Wegovy is a new tradename for semaglutide, a drug thats been approved to treat Type II diabetes since 2017, but which also won FDA approval as a weight loss medication in June of this year
doi: 10.1111/j.1365-2826.2008.01814.x 80 RichardCDTolleVLowMJ
Insurance and Cost: Navigating Financial Aspects Wondering about "zepbound cost" and whether insurance will cover it
The same is true here